nabumetone 750 MG Oral Tablet [Relafen]

RxNorm concept 206959, branded drug (sbd). Prescribable name: Relafen 750 MG Oral Tablet.

RxCUI: 206959
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/206959 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

nabumetone 31448

Other names

Relafen 750 MG Oral Tablet

Related concepts

nabumetone 750 MG (SCDC, consists of)
nabumetone 750 MG [Relafen] (SBDC, consists of)
Oral Tablet (DF, has dose form)
Relafen (BN, has ingredient)
nabumetone 750 MG Oral Tablet (SCD, tradename of)

Linked data

NDCs

73684010130
73684010160

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 206959 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/206959 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 206959. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.